Drug General Information
Drug ID
D0K4WS
Former ID
DNC009321
Drug Name
KNI-10152
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529771]
Structure
Download
2D MOL

3D MOL

Formula
C39H49N3O6S
Canonical SMILES
CC(C)C1=C(C(=CC=C1)C(C)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)<br />N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O
InChI
1S/C39H49N3O6S/c1-23(2)27-17-12-18-28(24(3)4)35(27)48-21-32(44)40-30(19-25-13-8-7-9-14-25)34(45)38(47)42-22-49-39(5,6)36(42)37(46)41-33-29-16-11-10-15-26(29)20-31(33)43/h7-18,23-24,30-31,33-34,36,43,45H,19-22H2,1-6H3,(H,40,44)(H,41,46)/t30-,31+,33-,34-,36+/m0/s1
InChIKey
QPUVMQNOWWLTBU-SQKWSBCUSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [529771]
References
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.